ABBOTT LABORATORIES — Director's Dealing 2015

Apr 2, 2015

Page 1 of 2

SEC FORM 3

SEC Form 3

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

3235OMB Number: 0104 Estimated average burden hours per 0.5 response:

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of ReportingPerson*NATH DEEPAK S.(Last)(First)(Middle)100 ABBOTT PARK ROAD(Street)ABBOTTPARKIL60064(City)(State)(Zip)	2. Date of EventRequiringStatement(Month/Day/Year)04/01/2015	2. Date of EventRequiringStatement(Month/Day/Year)04/01/2015	3. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	3. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	3. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	3. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	3. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	3. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]	3. Issuer NameandTicker or Trading SymbolABBOTT LABORATORIES [ABT]
			4. Relationship of Reporting Person(s) toIssuer(Check all applicable)Director10% OwnerXOfficer (givetitle below)Other(specifybelow)Senior Vice President				5. If Amendment, Date of OriginalFiled (Month/Day/Year)
							6. Individual or Joint/Group Filing(Check Applicable Line)XForm filed by OneReporting PersonForm filed by More thanOne Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)			2. Amount of SecuritiesBeneficially Owned(Instr. 4)		3.OwnershipForm: Direct(D) orIndirect (I)(Instr. 5)		4. Nature of Indirect BeneficialOwnership (Instr. 5)
Common shares without par value			35,757		D
Table II - Derivative Securities Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable andExpiration Date(Month/Day/Year)			3. Title and Amount ofSecurities UnderlyingDerivative Security (Instr. 4)		4.Conversionor ExercisePrice ofDerivativeSecurity		5.OwnershipForm:Direct (D)or Indirect(I) (Instr. 5)	6. Nature ofIndirectBeneficialOwnership(Instr. 5)
	DateExercisable	ExpirationDate		Title	AmountorNumberofShares
Option (right to buy)(1)	04/28/2015	04/27/2024		Common shares	15,553	38.1		D
Option (right to buy)(1)		04/27/2024		Common shares	15,552	38.1		D
	04/28/2016
Option (right to buy)(1)	04/28/2017	04/27/2024		Common shares	15,553	38.1		D
Option (right to buy)(1)	02/20/2016	02/19/2025		Common shares	38,231	47		D
Option (right to buy)(1)	02/20/2017	02/19/2025		Common shares	38,230	47		D
Option (right to buy)(1)	02/20/2018	02/19/2025		Common shares	38,231	47		D

Explanation of Responses:

1. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

04/02/2015

4/2/2015

Page 2 of 2

SEC FORM 3

John A. Berry, by power of attorney for Deepak S. Nath ** Signature of Reporting Date Person

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

4/2/2015